Related Experiment Videos

A review of the effects of dopaminergic agents in humans: implications for medication development

¹Laboratory of Clinical Psychopharmacology, National Institute on Drug Abuse Addiction Research Center, Baltimore, MD 21224, USA.

NIDA Research Monograph

|January 1, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine.

The Journal of pharmacology and experimental therapeutics·2009

Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.

Neuroscience·2008

Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.

Neuroscience·2007

An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.

Molecular pharmacology·2006

Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys.

The Journal of pharmacology and experimental therapeutics·2006

Alterations in alcohol consumption, withdrawal seizures, and monoamine transmission in rats treated with phentermine and 5-hydroxy-L-tryptophan.

Synapse (New York, N.Y.)·2006

See all related articles